Stryker Corp's stock is being evaluated for its value, with some outlets suggesting it may be undervalued. The company's product portfolio and growth prospects, including its Mako procedures, are being seen as potential drivers of growth. However, a recent cyberattack and the company's removal from the Russell 1000 Growth-Defensive Index may pose challenges to its performance.